Browse studies

Find your next paid study

1,847 recruiting studies matching your filters

A Phase Ib Study of Botensilimab Plus Balstilimab and Fasting-Mimicking Diet (FMD) Plus Vitamin C in Patients With KRAS-Mutant Metastatic Colorectal Cancer

This phase Ib trial tests the safety, side effects, and effectiveness of botensilimab, and balstilimab in combination with a fasting mimicking diet and high do…

Metastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v8

Estimated

~$10 – $6,250

University of Southern CaliforniaNCT06336902

Phase 4

Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria: A Feasibility Study

Patients with hepatocellular carcinoma (HCC) beyond Milan Criteria (MC) who are transplant-eligible will be treated with 6 months of neoadjuvant/downstaging at…

Hepatocellular CarcinomaHepatocellular Cancer

Estimated

~$10 – $6,250

The Methodist Hospital Research InstituteNCT05185505

Observational

MC230504 Safe Omission of Pelvic Lymph Node Dissection (SOuND ) During Radical Prostatectomy: Diagnostic Accuracy of rhPSMA-7.3(18F) PET/CT, mpMRI and Patient Clinical Factors to Predict Lymph Node Metastasis

This clinical trial evaluates the use of an imaging scan (18F-rhPSMA-7.3 positron emission tomography \[PET\]/magnetic resonance imaging \[MRI\]) for identifyi…

Localized Prostate CarcinomaOligometastatic Prostate CarcinomaStage I Prostate Cancer AJCC v8+3 more

Estimated

~$10 – $6,250

Mayo ClinicNCT06389786

Phase 2

A Phase II Study of Sacituzumab Govitecan in Combination With Cetuximab in Patients With Recurrent Metastatic HNSCC That Has Progressed After First-Line Therapy

The purpose of this study to find out whether sacituzumab govitecan in combination with cetuximab is an effective and safe treatment approach for people with r…

Squamous Cell Carcinoma of Head and NeckSinus CancerNasal Cavity Cancer+9 more

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07063212

Using Microbiome to Predict Durvalumab Toxicity in Post-CCRT NSCLC Patients (Microdurva)

This phase IV study is hoping to determine if examining the microbiome in non-small cell lung cancer participants who will receive durvalumab can predict treat…

NSCLC, Stage IIILocally Advanced Lung Carcinoma

Estimated

~$10 – $1,125

Jun Zhang, MD, PhDNCT04680377

Phase 2

S2210 A Phase II Study of Neoadjuvant Carboplatin for Localized, High Risk Prostate Cancer With Germline BRCA1/2 Mutations

This phase II trial tests how well carboplatin before surgery works in treating patients with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene mu…

Prostate AdenocarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8

Estimated

~$10 – $7,500

SWOG Cancer Research NetworkNCT05806515

Phase 2

Vaginal DHEA for Women With Gynecologic and Gastrointestinal Cancer After Radiation

This phase II trial tests the feasibility and side effects of vaginal DHEA to improve vaginal health after radiation for women with gynecologic, anal or rectal…

Anal CarcinomaCervical CarcinomaMalignant Female Reproductive System Neoplasm+3 more

Estimated

~$10 – $6,250

Ohio State University Comprehensive Cancer CenterNCT07407647

Phase 1

Phase I Trial of Radiotherapy in Combination With Atezolizumab in Borderline Resectable and Unresectable Cutaneous Squamous Cell Carcinoma(cSCC)

This phase I trial tests the safety and side effects radiotherapy in combination with atezolizumab in treating patients with cutaneous squamous cell cancer tha…

Locally Advanced Skin Squamous Cell CarcinomaResectable Skin Squamous Cell CarcinomaUnresectable Skin Squamous Cell Carcinoma

Estimated

~$10 – $6,250

City of Hope Medical CenterNCT05085496

Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test (eAArly DETECT)

The Mainz Biomed Colorectal Cancer Screening Test is being studied for its performance in the identification of the presence of colorectal cancer (CRC) or adva…

Colorectal Cancer ScreeningColorectal Cancer MetastaticColon Adenocarcinoma

Estimated

~$10 – $1,125

Mainz BiomedNCT06864338

Phase 1

Phase I/II Trial of Gabapentin Plus Ketamine for Prevention and Treatment of Acute and Chronic Pain in Locally Advanced Head and Neck Cancer Patients Undergoing Primary or Adjuvant Chemoradiation

This is a study to establish a safe and feasible dose for prophylactic use of a combination of gabapentin and ketamine in head and neck cancer patients undergo…

Head and Neck CancerLocally Advanced Head and Neck Carcinoma

Estimated

~$10 – $7,500

Natalie LockneyNCT05156060

Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy

This trial aims at investigating the diagnostic ability of a combined diagnostic panel including systematic endoscopic evaluation (SEE), blood-based ctDNA assa…

Urothelial CarcinomaMuscle Invasive Bladder Urothelial CarcinomaNon-Muscle Invasive Bladder Urothelial Carcinoma

Estimated

~$10 – $750

Fox Chase Cancer CenterNCT06396533

Observational

Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement

This purpose of this study is to examine the placement of proton spots during pencil beam scanning proton therapy for low and intermediate risk prostate cancer…

Prostate CancerProstate AdenocarcinomaProstate Carcinoma

Estimated

~$10 – $6,250

Covenant Health Cancer CenterNCT06200259